Related Experiment Videos

Double-blind administration of methylphenidate to mentally retarded children with attention deficit disorder; a

American Journal of Mental Deficiency
|May 1, 1982
PubMed

Insights

Methylphenidate may benefit children with mental retardation and attention disorders. Careful individual assessment is crucial for evaluating stimulant medication effectiveness in this population.

Area of Science:

  • Child Psychology
  • Neurodevelopmental Disorders
  • Pharmacology

Background:

  • Children with mental retardation often exhibit attention deficits and hyperactivity.
  • Special education programs serve children with intellectual disabilities and behavioral challenges.

Purpose of the Study:

  • To evaluate the efficacy of methylphenidate in children with mental retardation and attention deficit disorder symptoms.
  • To assess the impact of stimulant medication on behavior and attention in this specific pediatric population.

Main Methods:

  • An outpatient, double-blind, placebo-controlled crossover study.
  • Involved 10 children with IQs from 48 to 77 attending special education.
  • Utilized methylphenidate and assessed outcomes using Conners' rating scales.

Main Results:

  • Five out of ten children showed positive responses to methylphenidate.
  • Improvements were noted in parent and teacher ratings.
  • Individual variability in response was observed.

Conclusions:

  • Stimulant medication, such as methylphenidate, can positively affect mentally retarded children with high activity levels and attention disorders.
  • Individualized, controlled observational and behavioral assessments are essential for determining treatment efficacy.
  • Further research may explore optimal dosing and long-term effects.

Related Concept Videos